Skip to Content
UW Health SMPH
American Family Children's Hospital
SHARE TEXT


Like UW Carbone Cancer Center on Facebook

 

About UW Carbone Cancer Center

The UW Carbone Cancer Center (UWCCC) holds the unique distinction of being the only comprehensive cancer center in Wisconsin, as designated by the National Dr. Howard Bailey UWCCC Interim DirectorCancer Institute, the lead federal agency for cancer research. Every day on the UW-Madison campus, thousands of dedicated individuals work meticulously to find the best ways to prevent, detect, diagnose and treat cancer.

 

An integral part of the UW School of Medicine and Public Health, the UWCCC unites physicians and scientists who work together in translating discoveries from research laboratories into new treatments that benefit cancer patients.

More than 30,000 people are seen annually for diagnosis, therapy, follow-up care or consultations at UW Hospital and Clinics, as well as our other clinical locations.

 

The UWCCC leadership includes:

  • Howard Bailey, Interim Director
  • Paul Harari, Associate Director of Multidisciplinary, Translational Research
  • Brad Kahl, Associate Director of Clinical Research
  • James Shull, Associate Director of Laboratory Research
  • Maureen Smith, Associate Director of Cancer Control Research
  • Umberto Tachinardi, Associate Director of Informatics
  • Daniel Mulkerin, Medical Director, Oncology Services
  • Sharon Weber, Medical Director, Surgical Oncology


Leading Achievements

  • Developed an immunotherapy improving neuroblastoma outcomes by 50%
  • Developed tomotherapy - a specialized form of radiation therapy targeting cancer cells, avoiding other cells and organs
  • Instrumental in Wisconsin law improving patient access to clinical trials
  • Leading developer of virtual colonoscopy
  • Two $7 million federal grants received to fund housing for interdisciplinary prostate and breast cancer research
  • Established a palliative care unit at UW Hospital and Clinics
  • Chosen to lead a national consortium of five institutions to conduct multiple Phase I and II clinical trials of cancer chemopreventive agents
  • Developed tamoxifen, one of the best therapies for treating and preventing breast cancer
  • Introduced 5-flourouracil, widely used to treat breast, ovarian, stomach and colon cancers
  • Developed the conceptual basis for combination drug therapy
  • Led the first clinical trials with DFMO, a potential cancer-preventing agent that slows an enzyme involved in tumor growth
  • Nobel prize for elucidating the basis of viral carcinogenesis
  • Sponsored the nation's first telephone-based cancer helpline, which has now become the National Cancer Institute's Cancer Information Service
  • First radiation oncology department in country to have CT/PET scanning for treatment planning
  • Led the development of the Wisconsin Cancer Council and Wisconsin Cancer Pain Initiative


Learn more about the UWCCC: